Telesis Bio, Inc.

NASDAQ:TBIO

1.11 (USD) • At close November 7, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

20232022202120202019201820172016
Operating Activities:
Net Income -47.724-48.471-38.958-18.01-8.302-97.395-66.443-26.698
Depreciation & Amortization 4.1022.8751.5741.4570.8572.8411.5850.73
Deferred Income Tax -18.60902.3040.443-0.486-5.565-12.4810
Stock Based Compensation 3.9633.7271.0860.0430.01303.680.686
Change In Working Capital -7.7662.13-3.037-0.020.22584.365-9.481.064
Accounts Receivables -1.332-2.186-0.735-0.774-0.859000
Inventory -1.8250.168-1.4620.1110.723000
Accounts Payables -3.2851.163-0.2980.1420.2320.6584.0250.084
Other Working Capital -1.3242.985-0.5420.5010.12983.707-13.5050.98
Other Non Cash Items 31.3671.0240.3330.7062.448-13.71232.3510.5
Operating Cash Flow -34.667-38.715-36.698-15.381-6.39-22.133-50.788-23.718
Investing Activities:
Investments In Property Plant And Equipment -1.98-4.468-1.854-0.204-0.079-6.58-2.769-0.862
Acquisitions Net 0.016-0.556-13.18600000
Purchases Of Investments -33.775-77.42800-174.271-136.694-70.767-34.931
Sales Maturities Of Investments 29.99564.44500159.62257.98473.8441.901
Other Investing Activites -3.764-0.5560014.649000
Investing Cash Flow -5.744-18.007-15.04-0.204-0.079-85.290.3046.108
Financing Activities:
Debt Repayment -15.092-15.079-5.081-0.107-2.265000
Common Stock Issued 26.6570.528112.4840.01132.954117.44700
Common Stock Repurchased 00000000
Dividends Paid 00000000
Other Financing Activities 26.65719.06113.6780.011-0.113-3.82441.74750.747
Financing Cash Flow 11.5654.51121.081-0.09635.106113.62341.74750.747
Other Information:
Effect Of Forex Changes On Cash -0.0030000.669000
Net Change In Cash -28.849-52.21269.343-15.681-27.086.2-8.73733.137
Cash At End Of Period 1.74530.59482.80613.46329.14456.22450.02458.761